Trade Accuray - ARAY CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0202 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023679% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001457% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.7849 |
| Open | 1.7749 |
| 1-Year Change | -27.91% |
| Day's Range | 1.7549 - 1.8049 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 31, 2025 | 1.7849 | 0.0200 | 1.13% | 1.7649 | 1.8049 | 1.7449 |
| Mar 28, 2025 | 1.8149 | -0.0400 | -2.16% | 1.8549 | 1.8649 | 1.7749 |
| Mar 27, 2025 | 1.8749 | 0.0400 | 2.18% | 1.8349 | 1.8949 | 1.8249 |
| Mar 26, 2025 | 1.8549 | -0.0100 | -0.54% | 1.8649 | 1.8749 | 1.8449 |
| Mar 25, 2025 | 1.8849 | 0.0400 | 2.17% | 1.8449 | 1.9049 | 1.8449 |
| Mar 24, 2025 | 1.8949 | 0.0400 | 2.16% | 1.8549 | 1.9149 | 1.8449 |
| Mar 21, 2025 | 1.8449 | 0.0500 | 2.79% | 1.7949 | 1.8549 | 1.7649 |
| Mar 20, 2025 | 1.8349 | -0.0100 | -0.54% | 1.8449 | 1.8549 | 1.8249 |
| Mar 19, 2025 | 1.8649 | 0.0500 | 2.75% | 1.8149 | 1.8749 | 1.8049 |
| Mar 18, 2025 | 1.8049 | -0.0200 | -1.10% | 1.8249 | 1.8349 | 1.7949 |
| Mar 17, 2025 | 1.8549 | 0.0400 | 2.20% | 1.8149 | 1.8749 | 1.8149 |
| Mar 14, 2025 | 1.8149 | 0.0800 | 4.61% | 1.7349 | 1.8349 | 1.7349 |
| Mar 13, 2025 | 1.7349 | -0.0600 | -3.34% | 1.7949 | 1.7949 | 1.7249 |
| Mar 12, 2025 | 1.8149 | 0.0200 | 1.11% | 1.7949 | 1.8349 | 1.7649 |
| Mar 11, 2025 | 1.8049 | 0.0400 | 2.27% | 1.7649 | 1.8349 | 1.7449 |
| Mar 10, 2025 | 1.7849 | -0.0300 | -1.65% | 1.8149 | 1.8449 | 1.7549 |
| Mar 7, 2025 | 1.8549 | 0.0400 | 2.20% | 1.8149 | 1.8749 | 1.7949 |
| Mar 6, 2025 | 1.8249 | -0.0500 | -2.67% | 1.8749 | 1.9049 | 1.8049 |
| Mar 5, 2025 | 1.9049 | 0.0900 | 4.96% | 1.8149 | 1.9249 | 1.8149 |
| Mar 4, 2025 | 1.8449 | 0.0000 | 0.00% | 1.8449 | 1.8949 | 1.7949 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Accuray Company profile
About Accuray Incorporated
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports market-changing solutions that are designed to deliver radiation treatments. The Company's technologies include the CyberKnife and TomoTherapy platforms, including the Radixact System. The CyberKnife and TomoTherapy platform, which are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART). The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.
Financial summary
BRIEF: For the six months ended 31 December 2021, Accuray Incorporated revenues increased 22% to $223.7M. Net loss totaled $849K vs. income of $5.2M. Revenues reflect Product segment increase of 55% to $113.5M, Service segment increase of less than 1% to $110.2M, China (Country) segment increase of 98% to $49.2M, Americas segment increase of 37% to $75M. Net loss reflects Research and development increase of 21% to $28.4M (expense).
Equity composition
Common Stock, $.001 Par, 12/10, 100M auth., 61,865,443 issd., less 2,140,018 shs. in Treas. @ Cost. Insiders own 2.14%. IPO: 2/07, 16M shs. @ $18 per share by JPMorgan, UBS Investment Bank, Piper Jaffray, Jefferies & Co.
| Industry: | Advanced Medical Equipment & Technology (NEC) |
1240 Deming Way
MADISON
WISCONSIN 53717
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com